NDC 68071-2112

Truvada

Emtricitabine And Tenofovir Disoproxil Fumarate

Truvada is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Nucare Pharmaceuticals,inc.. The primary component is Emtricitabine; Tenofovir Disoproxil Fumarate.

Product ID68071-2112_82fa11c2-9b79-c44a-e053-2991aa0a3a80
NDC68071-2112
Product TypeHuman Prescription Drug
Proprietary NameTruvada
Generic NameEmtricitabine And Tenofovir Disoproxil Fumarate
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2004-08-02
Marketing CategoryNDA / NDA
Application NumberNDA021752
Labeler NameNuCare Pharmaceuticals,Inc.
Substance NameEMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE
Active Ingredient Strength200 mg/1; mg/1
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 68071-2112-3

3 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68071-2112-3)
Marketing Start Date2017-01-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 68071-2112-3 [68071211203]

Truvada TABLET, FILM COATED
Marketing CategoryNDA
Application NumberNDA021752
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-01-24

Drug Details

Active Ingredients

IngredientStrength
EMTRICITABINE200 mg/1

OpenFDA Data

SPL SET ID:46e06df0-654d-43cc-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 639888
  • 476556
  • UPC Code
  • 0368071211238
  • Pharmacological Class

    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleosides [CS]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleosides [CS]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]

    NDC Crossover Matching brand name "Truvada" or generic name "Emtricitabine And Tenofovir Disoproxil Fumarate"

    NDCBrand NameGeneric Name
    35356-070Truvadaemtricitabine and tenofovir disoproxil fumarate
    50090-0870Truvadaemtricitabine and tenofovir disoproxil fumarate
    52959-969Truvadaemtricitabine and tenofovir disoproxil fumarate
    53808-0805Truvadaemtricitabine and tenofovir disoproxil fumarate
    61919-669TRUVADAemtricitabine and tenofovir disoproxil fumarate
    61958-0701Truvadaemtricitabine and tenofovir disoproxil fumarate
    68071-2112TruvadaTruvada
    69189-0701TruvadaTruvada
    70518-0097TruvadaTruvada
    61958-0704TruvadaTruvada
    61958-0705TruvadaTruvada
    61958-0703TruvadaTruvada
    63629-7581TruvadaTruvada
    67296-1237TruvadaTruvada
    0093-7607Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    0093-7704Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    0378-1930Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    0904-7172Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    16714-534Emtricitabine and tenofovir disoproxil fumarateEmtricitabine and tenofovir disoproxil fumarate
    31722-560Emtricitabine and tenofovir disoproxil fumarateEmtricitabine and tenofovir disoproxil fumarate
    33342-106Emtricitabine and tenofovir disoproxil fumarateEmtricitabine and tenofovir disoproxil fumarate
    42291-439Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    42385-913Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    42385-953Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    42543-719Emtricitabine and Tenofovir Disoproxil FumarateEMTRICITABINE and TENOFOVIR Disoproxil Fumarate
    50090-5957EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATEEMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
    51407-112Emtricitabine and Tenofovir Disoproxil FumarateEMTRICITABINE and TENOFOVIR Disoproxil Fumarate
    60219-2092Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    60219-2093Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    60219-2094Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    60219-2095Emtricitabine and Tenofovir Disoproxil FumarateEmtricitabine and Tenofovir Disoproxil Fumarate
    60505-4202Emtricitabine and Tenofovir Disoproxil Fumarateemtricitabine and tenofovir disoproxil fumarate

    Trademark Results [Truvada]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    TRUVADA
    TRUVADA
    78239720 2915213 Live/Registered
    Gilead Sciences, Inc.
    2003-04-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.